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ABSTRACT
Background Contact tracing is a key element in
England’s 2015 collaborative TB strategy, although
proposed indicators of successful contact tracing remain
undescribed.
Methods We conducted descriptive and multivariable
analyses of contact tracing of TB cases in London
between 1 July 2012 and 31 December 2015 using
cohort review data from London’s TB Register,
identifying characteristics associated with improved
indicators and yield.
Results Of the pulmonary TB cases notiﬁed, 60%
(2716/4561) had sufﬁcient information for inclusion. Of
these, 91% (2481/2716) had at least 1 contact
(median: 4/case (IQR: 2–6)) identiﬁed, with 86%
(10 251/11 981) of these contacts evaluated. 4.1%
(177/4328), 1.3% (45/3421) and 0.70% (51/7264) of
evaluated contacts of pulmonary smear-positive,
pulmonary smear-negative and non-pulmonary cases,
respectively, had active disease. Cases who were former
prisoners or male were less likely to have at least one
contact identiﬁed than those never imprisoned or
female, respectively. Cases diagnosed at clinics with
more directly observed therapy or social workers were
more likely to have one or more contacts identiﬁed.
Contacts screened at a different clinic to their index case
or of male index cases were less likely to be evaluated
than those screened at the same clinic or of women,
respectively; yield of active disease was similar by sex.
10% (490/4850) of evaluated child contacts had latent
TB infection.
Conclusions These are the ﬁrst London-wide estimates
of TB contact tracing indicators which are important for
monitoring the strategy’s success and informing risk
assessment of index cases. Understanding why
differences in indicators occur between groups could
improve contact tracing outcomes.
INTRODUCTION
In 2015, there were 10.4 million incident TB cases
and 1.4 million deaths worldwide, making TB the
largest cause of death by a single infectious agent.1
While England is a low burden country, with 5758
notiﬁed cases in 2015, 39% of these occurred in
London,2–4 where overall incidence was 26/
100 000/year; in 2014, it reached 79/100 000/year
in one London borough.4 While incidence remains
highest among the foreign-born, and many cases
are likely due to reactivation of infection acquired
abroad, molecular epidemiological analyses
attribute up to a third of new cases in London to
recent transmission.5 UK-born patients with TB
and those of white ethnicity, 25% of whom have
social risk factors, were frequently ‘clustered’ and
also more likely to have delays exceeding 4 months
from symptom onset to starting treatment.4 The
Collaborative Tuberculosis Strategy for England,3
published in 2015, highlights contact tracing as an
important tool for improving early TB diagnosis
and reducing transmission. Contact tracing, which
seeks to identify and diagnose contacts of infectious
cases, has been used for decades in high-income
countries where the heightened risk of disease
among contacts relative to the general population
makes it effective.6–8 The strategy proposes two
indicators of improved contact tracing: the propor-
tion of pulmonary TB cases with close contacts
identiﬁed, and the proportion of identiﬁed close
contacts of pulmonary TB cases that are evaluated.
TB contact tracing in England broadly follows
the stone-in-the-pond principle.9 Clinics evaluate
Key messages
What is the key question?
▸ In London, what is the baseline level of contact
tracing indicators for the Public Health England
and National Health Service England
collaborative TB strategy?
What is the bottom line?
▸ In London 91% of pulmonary index cases have
at least one contact identiﬁed and 86% of
those identiﬁed are evaluated for signs of TB
and latent infection; there were signiﬁcant
differences in these indicators between cases,
including when grouped by the sex of the case,
whether they have social risk factors, and the
stafﬁng levels of the clinic.
Why read on?
▸ These results provide an important baseline for
monitoring progress of England’s national TB
strategy and highlight areas in which
improvements can be made, particularly those
which show improved indicators for contacts
screened at the same clinic as their index case
or clinics with a greater number of directly
observed therapy (DOT) or social workers.
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close contacts (those with contact similar to that in a household)
ﬁrst, followed by casual contacts (eg, workplace or school con-
tacts) if ﬁrst round investigations suggest transmission to close
contacts has occurred. In England, until 2016, guidance recom-
mended identiﬁcation and evaluation of household contacts of
all index cases, after which tracing just household contacts of
index cases with pulmonary or laryngeal disease was recom-
mended.7 In 2010, cohort review, an approach to case manage-
ment and contact investigation appraisal that was shown to
improve case management outcomes, was ﬁrst introduced to
London, and occurs quarterly.10 11
Several studies have found differences in both the proportion
of TB contacts evaluated and the yield (the proportion of evalu-
ated contacts diagnosed with TB) between ethnic groups and
different disease types in the UK12–14 and elsewhere.15–17 The
ﬁndings and understanding gained from such studies are not
readily transferable to the large and ethnically diverse metrop-
olis of London. Using data on contact tracing collected in
London through cohort review since mid-2012, the main aim of
this study is the presentation of baseline levels of the strategy
contact tracing indicators, and of the proportion of contacts
who are secondary cases or have latent TB infection (LTBI) (the
‘yield’). A secondary aim is the identiﬁcation of demographic
and clinical characteristics associated with different indicators
and yield estimates.
METHODS
Deﬁnition of terms
During the study period (1 July 2012–31 December 2015, see
below), immediately after the diagnosis of the index case, the
nurse asked the case for a list of close contacts. These contacts
were then requested to attend for screening as soon as possible.
Screening begins with symptom-screen; for asymptomatic con-
tacts this is followed by a tuberculin skin test (TST) or interferon
γ release assay (IGRA) in those under 35 years and consideration
of a chest X-ray (CXR) in those 35 years and over.7 Those with a
positive symptom-screening, TST/IGRA result or CXR are evalu-
ated for signs of active TB. LTBI is deﬁned as a positive result on
either a TST or IGRA, which both have variable sensitivity,6 and
the absence of active disease. Those with LTBI are considered for
preventive therapy and/or BCG vaccination. The numbers of con-
tacts with TB is recorded in the London TB Register (LTBR) at
the initial contact investigation, so all new cases of TB among
contacts can be considered prevalent.18 19
Data set and inclusion criteria
The primary data source was the LTBR, a web-based register
containing demographic and clinical data on all TB cases noti-
ﬁed in London since 2002. Clinical and demographic informa-
tion on patients is entered directly to the LTBR by TB clinic
staff. We restricted analyses to data collected after the introduc-
tion of cohort review (1 July 2012), after which the database
includes data on the aggregate number of contacts per case that
were: identiﬁed, evaluated, found to have LTBI and/or active
TB. Contact data were aggregated by whether the contact was a
child or adult (15 years old or above) and whether they were
evaluated at the same clinic as the index case or elsewhere. As
only contacts aged less than 35 years were evaluated for LTBI,
data on LTBI status of contacts was only used for child contacts.
No other demographic data on contacts were collected.
Individual level data were not available for whether a home visit
was undertaken; instead, the clinic’s policy was used to provide
clinic-level data. Only data from household and other close con-
tacts are included in the analysis.
London is divided into ﬁve sectors; in some of these, a non-
random selection of cases was reported at cohort review and
recorded in the LTBR. To avoid bias, we only included cases in
the analysis if the sector in which they were notiﬁed reported
80% or more of their cases at cohort review in a given quarter
(deﬁned as at least one of the cohort review ﬁelds completed)
(see online supplementary appendix for a description of
included quarters by sector). Selection of quarters was done
separately for analyses including all cases, or just pulmonary
cases (see online supplementary appendix). We removed
further cases if: their line listing contained inconsistencies (eg,
more contacts evaluated than were identiﬁed); included con-
tacts were probably casual contacts (an incident was declared
and more than 20 close contacts were identiﬁed); a patient
was not reported to cohort review; or the index was detected
through a previous contact investigation. In multivariable ana-
lyses, we also removed cases if data on an included exposure
were missing. If the ﬁeld describing number of contacts was
missing, we assumed it was zero if other cohort review ﬁelds
were complete and this assumption did not create
inconsistencies.
Indicators
We calculated the following four indicators:
1. The proportion of pulmonary index cases who had at least
one contact identiﬁed;
2. The proportion of identiﬁed contacts of pulmonary index
cases who were evaluated;
3. The proportion of all evaluated contacts that had active TB
(‘Yield of active disease per contact’);
4. The proportion of all evaluated child contacts that had LTBI
(‘Yield of LTBI per child contact’).
Indicators 1 and 2 were proposed in the National Health
Service England and Public Health England collaborative strat-
egy3 and are recommended in the US Centers for Disease
Control and Prevention guidelines,20 while indicators 2, 3 and 4
were used in a systematic review of European contact investiga-
tions.15 As WHO and European Centre for Disease Prevention
and Contro guidelines refer to low-income/middle-income
countries and multidrug-resistant cases, respectively, we did not
focus on these indicators here.21 22 Indicators 1 and 2 include
only pulmonary index cases, whereas indicators 3 and 4 include
all index cases, in order to estimate the yield from screening
contacts of non-pulmonary cases. While LTBI treatment is an
important outcome of contact tracing in England, it is not
covered in this article.
Statistical analysis
We calculated the four indicators London-wide and for subsets
of index cases (based on disease site, smear status, age of
contact and ethnic group). We used multivariable logistic regres-
sion to assess the association of clinical and demographic factors
of the index cases, contacts, clinics and local authorities with
whether or not the index case (indicator 1) or contact (indica-
tors 2–4) satisﬁes each of the four indicators (see online supple-
mentary table S1 for details of included variables). As this was
an exploratory study all clinical and demographic factors with a
plausible direct or confounding impact on the outcome were
included in the model (see online supplementary appendix for
the exposures included). We assessed all variables for multicolli-
nearity. For indicators 2–4, as each index case may have several
contacts, index case exposures tend to cluster; adjustments were
made to the p values and CIs to account for this, using the
between-cluster variance estimator in Stata.23 For indicator 4,
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we excluded adult contacts, as we did not know which of them
were tested for LTBI.
Note that there may be discrepancies between numbers pre-
sented for the levels of the indicators and for the multivariable
analysis, due to cases missing data on variables included in the
multivariable analysis. All data were analysed using Microsoft
Excel V.14.0 and Stata V.13.1.
RESULTS
Comparison of included and excluded cases
From 1 July 2012 to 31 December 2015 inclusive, 9821 cases
were reported in the LTBR of which 4561 were pulmonary.
After excluding cases, 5491 cases of all forms of TB and 2716
pulmonary cases remained (ﬁgure 1). When considering all
cases, there were 971 (18%) pulmonary smear-positive cases,
1095 (20%) pulmonary smear-negative cases, 478 (8.7%) pul-
monary cases with unknown smear, four laryngeal cases without
pulmonary involvement and 2943 (54%) non-pulmonary, non-
laryngeal cases. In general, included and excluded cases shared
similar clinical and demographic factors (table 1).
Indicator 1. Proportion of pulmonary index cases who had
at least one contact identiﬁed
Of 2716 index cases with pulmonary disease, 2481 (91%) had
at least one contact identiﬁed (table 2). This led to 12 248
contacts identiﬁed, a mean and median of 4.5 (95% CI 4.36 to
4.66) and 4 (IQR: 2–6) per index case, respectively. Table 3
shows the predictors of having at least one contact identiﬁed;
the multivariable analysis is restricted to those with complete
data on the variables included, limiting the sample from 2716
to 2327 of which 2168 (93%) cases had at least one contact
identiﬁed. Male cases were less likely than female cases to have
at least one contact identiﬁed (adjusted OR (aOR): 0.46 (0.30
to 0.68,)), as were those with a history of imprisonment com-
pared with those without a history of imprisonment (aOR:
0.27 (0.14 to 0.52)), those of black African ethnicity compared
with those of Indian ethnicity (aOR: 0.47 (0.27 to 0.83)) and
recent migrants compared with long-term migrants (aOR: 0.54
(0.35 to 0.84)). Smear-positive index cases were more likely to
have at least one contact identiﬁed compared with smear-
negative index cases (aOR: 1.84 (1.20 to 2.82)). There was a
signiﬁcant positive linear association between the number of
social care or directly observed therapy (DOT) workers (aOR
per staff per 100 cases: 1.36 (1.07 to 1.72)) at the clinic and
whether a case had at least one contact identiﬁed. These asso-
ciations were similar for the proportion of index cases with
three or more contacts named, or with ﬁve or more, except
that index cases with a history of drug use were more likely to
have three or more contacts named than those without (data
not shown).
Figure 1 Description of included and
excluded cases. LTBR, London TB
Register.
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Indicator 2. Proportion of contacts of pulmonary index cases
that were evaluated
Of the 12 248 contacts identiﬁed, 11 981 had data on age and
screening location and were included in this analysis. Of these,
10 251 (86%) were evaluated (table 2), with a mean and
median of 3.9 (95% CI 3.72 to 4.00) and 3 (IQR: 1–5) per
index case, respectively. The multivariable analysis of predic-
tors of a contact being evaluated in table 4 is restricted to those
with complete data on the variables included, limiting the
sample of contacts from 11 981 to 10 476 of which 8986
(86%) were evaluated. Identiﬁed contacts of male index cases
were less likely to be evaluated than those of female index
cases (aOR: 0.68 (0.54 to 0.85)), as were contacts aged over
14 years (aOR: 0.30 (0.24 to 0.39)) when compared with
those aged under 15 years. Contacts screened at the clinic of
their index case (aOR: 1.65 (1.26 to 2.16)) were more likely to
be evaluated than those screened elsewhere. Identiﬁed contacts
of index cases notiﬁed in boroughs with higher notiﬁcation
rates (aOR per 10 cases per 100 000: 0.93 (0.87 to 0.99)), and
contacts of index cases of white ethnicity (compared with
Indian index cases, aOR: 0.61 (0.42 to 0.90)) were less likely
to be evaluated, though these two associations were weaker.
Indicator 3. Proportion of evaluated contacts diagnosed
with active TB
Of the 16 495 contacts (of index cases with disease at any site)
evaluated, and no longer under investigation for signs of TB at
the time of the study, 294 (1.8%, 95% CI 1.6% to 2.0%) were
diagnosed with active TB (table 2). This ﬁgure rises to 2.6%
(243/9213) (95% CI 2.3% to 3.0%) and 4.1% (177/4328)
(95% CI 3.5% to 4.7%) for the contacts of pulmonary index
cases and sputum smear-positive pulmonary index cases,
respectively. This ﬁgure drops to 1.3% (45/3421) (95% CI
0.98% to 1.8%) and 0.70% (51/7264) (95% CI 0.51% to
0.89%) for the contacts of smear-negative pulmonary cases
index cases and index cases without pulmonary or laryngeal
involvement, respectively. Considering just index cases within
the black African ethnic group (the ethnic group with the
Table 1 Comparison of characteristics of cases that were included and excluded in the analyses. Percentages are within-group column
percentages with the exception of the total row, where row percentages are given. Within-group totals may be discrepant to the stated total due
to cases with missing data
Factor
Index cases with all forms of TB Index cases with pulmonary TB
Number included (%) Number excluded (%) Number included (%) Number excluded (%)
Total 5491 (56%) 4330 (44%) 2716 (60%) 1845 (40%)
UK-born?
Yes 830 (19%) 943 (17%) 622 (23%) 500 (27%)
No 2880 (67%) 3862 (70%) 1744 (64%) 1093 (60%)
No, recent migrant (<2 years) 578 (13%) 674 (12%) 344 (13%) 233 (13%)
Ethnicity
Bangladeshi 257 (5%) 317 (7%) 105 (4%) 85 (5%)
Black-African 1278 (23%) 726 (17%) 608 (22%) 361 (20%)
Black-Caribbean 208 (4%) 118 (3%) 116 (4%) 66 (4%)
Black-Other 82 (2%) 58 (1%) 40 (2%) 29 (2%)
Chinese 81 (1%) 37 (1%) 52 (2%) 19 (1%)
Indian 1330 (24%) 1434 (33%) 510 (19%) 461 (25%)
Pakistani 976 (18%) 607 (14%) 496 (18%) 290 (16%)
White 498 (9%) 525 (12%) 201 (7%) 189 (10%)
Other 758 (14%) 476 (11%) 578 (21%) 330 (18%)
Sex
Male 3287 (60%) 2537 (59%) 1704 (63%) 1122 (61%)
Female 2204 (40%) 1793 (41%) 1012 (37%) 723 (39%)
Site of disease
Pulmonary or laryngeal 2548 (46%) 2018 (47%) N/a N/a
Non-pulmonary and non-laryngeal 2943 (54%) 2312 (53%) N/a N/a
Social risk factor
History of homelessness 230 (4%) 130 (3%) 187 (7%) 90 (5%)
History of imprisonment 127 (2%) 76 (2%) 105 (4%) 50 (3%)
History of drug use 229 (4%) 141 (3%) 179 (7%) 101 (6%)
BCG vaccinated
Yes 3136 (58%) 2627 (61%) 1541 (58%) 1115 (61%)
No 1117 (21%) 848 (19%) 568 (21%) 354 (19%)
Unknown 1129 (21%) 800 (19%) 563 (21%) 351 (19%)
Age
15 years old or over 5367 (98%) 4046 (93%) 2641 (97%) 1658 (90%)
Under 15 years old 124 (2%) 284 (7%) 75 (3%) 187 (10%)
Home visits policy
Yes 1179 (32%) 369 (9%) 907 (33%) 230 (13%)
No 3712 (68%) 3927 (91%) 1801 (67%) 1593 (87%)
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highest yield of active disease per contact) 2.8% (107/3817)
(95% CI 2.3% to 3.3%) of evaluated contacts had active
disease. For index cases aged under 15 years, 5.5% (27/491)
(95% CI 3.5% to 7.5%) of their evaluated contacts had active
disease. The multivariable analysis of predictors of an evaluated
contact being diagnosed with TB in table 5 is restricted to those
with complete data on the variables included, limiting the
sample from 16 495 to 14 614 contacts of which 263 (1.8%)
were diagnosed with TB. Adult contacts were associated with
lower yields of active TB per contact (aOR: 0.55 (0.40 to 0.75))
(compared with child contacts). Additionally, index cases aged
below 15 years, of black African ethnicity or with pulmonary or
laryngeal disease (especially those who are smear-positive) were
associated with contacts having an increased risk of active
disease. None of the assessed social risk factors (history of
homelessness, drug use or imprisonment) for the index case
were associated with the contact having active TB.
Indicator 4. Proportion of evaluated child contacts
diagnosed with LTBI
Of the 4850 child contacts evaluated and no longer under inves-
tigation for signs of TB at the time of the study, 490 (10%, 95%
CI 9.3% to 11%) were diagnosed with LTBI (table 2). This
ﬁgure rises to 26% (277/1046) (95% CI 24% to 29%) for con-
tacts of sputum smear-positive pulmonary index cases only, and
drops to 9.5% (93/980) (95% CI 7.8% to 11%) and 3.3% (78/
2386) (95% CI 2.6% to 4.0%) for the contacts of smear-
negative pulmonary index cases and cases without pulmonary or
laryngeal involvement, respectively. For index cases aged under
15 years, 17% (32/184) (95% CI 12% to 23%) of their evalu-
ated child contacts had LTBI. The multivariable analysis of pre-
dictors of a child contact being diagnosed with TB in table 6 is
restricted to those with complete data on the variables included,
limiting the sample from 4850 to 4305 child contacts of which
440 (10%) were found to have LTBI. Pulmonary smear-negative
(aOR: 2.92 (1.96 to 4.35)) and pulmonary smear-positive index
cases (aOR: 8.39 (5.76 to 12.2)) (both relative to non-
pulmonary and non-laryngeal index cases) were positively asso-
ciated with child contacts having LTBI (table 6). Conversely,
culture-negative index cases (aOR relative to culture-positive
index cases: 0.51 (0.34 to 0.76)) were negatively associated with
child contacts having LTBI. None of the assessed social risk
factors (a history of homelessness, drug use or imprisonment)
for the index case were associated with child contacts having
LTBI, though the numbers were very small.
DISCUSSION
Our analyses provide the ﬁrst estimates of indicators that will be
used to monitor TB contact tracing in England, as part of the
Collaborative Tuberculosis Strategy for England. We found that
91% of pulmonary TB cases in London had at least one contact
identiﬁed and 86% of those contacts were investigated. For all
index cases, 1.8% of evaluated contacts had active TB disease
and 10% of child contacts had LTBI. The proportion of contacts
diagnosed with TB or LTBI was almost ﬁvefold greater for con-
tacts of pulmonary or laryngeal index cases than for index cases
with other disease types. Compared with female index cases,
male index cases had fewer contacts identiﬁed, and fewer of
those identiﬁed were evaluated, but sex had no signiﬁcant effect
on whether a case’s evaluated contacts had LTBI or TB disease.
Perhaps surprisingly, social risk factors were generally not sig-
niﬁcantly associated with either identifying contacts, evaluating
those contacts, or for the resultant TB or LTBI yield per
contact, the exception being that those with a prison history
were less likely to have contacts identiﬁed compared with those
without a prison history. The study may however have been
underpowered to discern these relationships, as only around 5%
of included index cases had each social risk factor. Contacts of
children were more likely than those of adults to be diagnosed
with TB; in the former circumstance, it is more likely that
one of the contacts diagnosed with TB was the source case for
that child.
By using data elicited through cohort review, we could
include more information than that available from routine sur-
veillance. One limitation was that data from several clinics for
some periods had to be excluded as cohort review was done
selectively (see online supplementary appendix). We mitigated
this potential source of bias by only using data from clinics that
reported 80% or more of their contacts, although some differ-
ences between included and excluded cases remained (table 1)
and it reduced the power of the study. Also, cases removed from
the multivariable analysis due to missing variables were more
likely to be culture-positive, white, UK-born or homeless, and
less likely to be screened at the clinic, than those included. It is
difﬁcult to predict the impact of these exclusions on the results.
However, the proportion of contacts evaluated (86%) may be
an overestimate, given that both more contacts of white index
cases and fewer contacts screened at the clinic are excluded than
included. Further, as more contacts of children were excluded
than included (table 1), it is possible that the estimates of yield
of TB and LTBI among contacts are underestimates. A second
Table 2 Levels of indicators and outcomes over study period
Indicator Number positive/total Percentage (95% CI)
1. The proportion of pulmonary index cases who have at least one contact identified 2481/2716 91% (90% to 92%)
The proportion of pulmonary index cases who have at least three contacts identified 1810/2716 67% (65% to 68%)
The proportion of pulmonary index cases who have at least five contacts identified 1093/2716 40% (38% to 42%)
2. The proportion of identified contacts of pulmonary index cases who are evaluated 10 251/11 981 86% (85% to 86%)
3. The proportion of evaluated contacts that have active TB 294/16 495 1.8% (1.6% to 2.0%)
The proportion of evaluated contacts of pulmonary smear-positive index cases that have active TB 177/4328 4.1% (3.5% to 4.7%)
The proportion of evaluated contacts of pulmonary smear-negative index cases that have active TB 45/3421 1.3% (0.98% to 1.8%)
The proportion of evaluated contacts of non-pulmonary and non-laryngeal index cases that have active TB 51/7264 0.70% (0.51% to 0.89%)
4. The proportion of evaluated child contacts that have LTBI 490/4850 10% (9.3% to 11%)
The proportion of evaluated child contacts of pulmonary smear-positive index cases that have LTBI 277/1046 26% (24% to 29%)
The proportion of evaluated child contacts of pulmonary smear-negative index cases that have LTBI 93/980 9.5% (7.8% to 11%)
The proportion of evaluated child contacts of non-pulmonary and non-laryngeal index cases that have LTBI 78/2386 3.3% (2.6% to 4.0%)
LTBI, latent TB infection.
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limitation is that little data were collected on individual contacts,
potentially masking important determinants of contact out-
comes, including the length and intensity of exposure, and risk
factors increasing the chance of the contact progressing to
disease. A third limitation is that the available data come from a
relatively short period (42 months), so temporal trends were
indiscernible. Unfortunately, data on the HIV status of index
cases are not recorded in the LTBR. Finally, the number of
patients with multidrug-resistant and extensively drug-resistant
TB was too small to do a subgroup analysis of this group.
The proportion of pulmonary index cases with at least one
contact identiﬁed (91%) compares favourably with previous
ﬁgures for one sector of London in 2012, namely 78% and
88% before and after cohort review, respectively.11 It is also
comparable to recent ﬁndings from the USA where the corre-
sponding ﬁgures were 94% and 86% for smear-positive and
smear-negative, culture-positive index cases, respectively,24 and
higher than the ﬁgure in Piedmont, Italy (77%).17 Similarly, the
proportion of identiﬁed contacts who were evaluated (88%) was
higher than the north central London (74% precohort review,
82% postcohort review) and US ﬁgures (82% for smear-
positives, 81% for smear-negatives). These ﬁgures suggest
London TB clinics undertake high quality contact tracing,
although further improvements in certain groups may be
Table 3 Associations with pulmonary index cases having at least one contact named (indicator 1)
Characteristics of the index case
At least one contact identified
Yes (row %)* No* aOR (95% CI) p Value
Total 2168 (93%) 159 N/a N/a
UK born
Yes 506 (94%) 31 1.16 (0.71 to 1.91) 0.01
No, long-term migrant 1390 (94%) 94 1
No, recent migrant 272 (89%) 34 0.54 (0.35 to 0.84)
History of drug use
Yes 133 (92%) 11 1.57 (0.73 to 1.37) 0.25
No 2035 (93%) 148 1
History of homelessness
Yes 123 (85%) 21 0.56 (0.31 to 1.01) 0.06
No 2045 (94%) 138 1
Former prisoner
Yes 76 (81%) 18 0.27 (0.14 to 0.52) <0.01
No 2092 (94%) 141 1
Sex
Male 1320 (91%) 124 0.46 (0.30 to 0.68) <0.01
Female 848 (96%) 35 1
Ethnicity
Indian 417 (95%) 20 1 <0.01
Black-African 468 (89%) 59 0.47 (0.27 to 0.83)
White 431 (93%) 34 0.73 (0.38 to 1.41)
Other 852 (95%) 46 1.06 (0.61 to 1.85)
Culture
Positive 1684 (94%) 104 1 0.02
Negative 419 (90%) 46 0.59 (0.40 to 0.89)
Not done 65 (88%) 9 0.52 (0.23 to 1.16)
Smear
Negative 945 (92%) 79 1 <0.01
Not done 367 (90%) 40 0.69 (0.44 to 1.06)
Positive 856 (96%) 40 1.84 (1.20 to 2.82)
Clinic case count (linear, 100 cases/year) x¼ 1:2 s=0.58 0.72 (0.46 to 1.12) 0.15
Clinic policy of home visits*
Yes 714 (92%) 64 0.66 (0.44 to 0.99) 0.04
No 1454 (94%) 95 1
Age of index case
0–14 years 63 (97%) 2 1 0.19
15 years and over 2105 (93%) 157 0.36 (0.08 to 1.62)
Notification rate*† (linear, 10 cases/100 000 population/year) x¼ 3:7 s=0.58 1.10 (0.98 to 1.23) 0.10
Nurses* (linear, nurses/100 cases/year) x¼ 3:5 s=0.87 0.90 (0.63 to 1.28) 0.54
Admin staff* (linear, staff/100 cases/year) x¼ 1:0 s=0.63 0.81 (0.50 to 1.31) 0.39
Social workers/DOT staff* (linear, staff/100 cases/year) x¼ 0:88 s=0.87 1.36 (1.07 to 1.72) 0.01
Adjusted OR (aOR) has been adjusted for everything in the table.
*Mean and SD presented for continuous variables.
†Notification rate in the year and local authority in which the index case was notified. N=2327.
DOT, directly observed therapy.
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feasible. Note that the higher proportion of smear-positive
index cases with at least one contact identiﬁed than smear-
negative index cases, found in this study and others, is likely
due to clinics’ need to focus limited resources on those index
cases for whom the yield is likely to be highest. The yield per
contact of all forms of TB in this study was higher than from a
similar study in Birmingham, another high incidence inner city
region of the UK, in 1990–2010.14 That study found a yield per
contact of active TB of 3.3% (compared with 4.1% in this
study) and 0.58% (versus 0.70% in this study) for smear-
positive pulmonary and non-pulmonary index cases, respect-
ively. The yield per contact of active TB among contacts of pul-
monary index cases presented here (2.6%) is high relative to
other studies in high-income settings. A systematic review of
Table 4 Associations with contacts of pulmonary index cases being evaluated (indicator 2)
Characteristics of the index case
Contact evaluated
Yes (row %)* No* aOR (95%CI) p Value
Total 8986 (86%) 1490 N/a N/a
UK born
Yes 2240 (86%) 907 1.22 (0.92 to 1.61) 0.13
No, long-term migrant 5692 (86%) 357 1
No, recent migrant 1054 (82%) 226 0.82 (0.59 to 1.13)
History of drug use
Yes 564 (80%) 137 0.99 (0.60 to 1.62) 0.97
No 8422 (86%) 1353 1
History of homelessness
Yes 480 (77%) 147 0.66 (0.40 to 1.06) 0.09
No 8506 (86%) 1343 1
Former prisoner
Yes 8708 (86%) 1400 0.63 (0.35 to 1.14) 0.13
No 278 (76%) 90 1
Sex
Male 5106 (83%) 1024 0.68 (0.54 to 0.85) <0.01
Female 3880 (89%) 466 1
Ethnicity
Indian 1690 (87%) 263 1 0.05
Black African 1985 (88%) 275 0.88 (0.62 to 1.25)
White 1739 (82%) 378 0.61 (0.42 to 0.90)
Other 3572 (86%) 574 0.93 (0.69 to 1.25)
Culture
Positive 7221 (86%) 1174 1 0.46
Negative 1507 (84%) 280 0.84 (0.63 to 1.11)
Not done 258 (88%) 36 1.03 (0.48 to 2.21)
Smear
Negative 3391 (84%) 625 1 0.14
Not done 1285 (85%) 220 1.02 (0.74 to 1.41)
Positive 4310 (87%) 645 1.27 (1.00 to 1.61)
Clinic case count* (linear, 100 cases/year) x¼ 1:2 s=0.58 0.81 (0.64 to 1.04)
Clinic policy of home visits
Yes 3078 (87%) 480 1.09 (0.82 to 1.43) 0.56
No 5908 (85%) 1010 1
Age of index case
0–14 years 292 (90%) 34 1 0.93
15 years and over 8694 (86%) 1456 0.97 (0.53 to 1.80)
Notification rate*† (linear, 10 cases/100 000 population/year) x¼ 3:8 s=2.1 0.93 (0.87 to 0.99) 0.02
Nurses* (linear, nurses/100 cases/year) x¼ 3:4 s=0.87 0.89 (0.72 to 1.09) 0.26
Admin staff* (linear, staff/100 cases/year) x¼ 0:99 s=0.60 1.17 (0.86 to 1.60) 0.32
Social workers/DOT staff* (linear, staff/100 cases/year) x¼ 0:89 s=0.89 0.95 (0.81 to 1.10) 0.47
Age of contact
15 years and over 6569 (83%) 1344 0.30 (0.24 to 0.39) <0.01
0–14 years 2417 (94%) 146 1
Contact screened at clinic
Yes 7629 (87%) 1147 1.65 (1.26 to 2.16) <0.01
No 1357 (80%) 343 1
*Mean and SD presented for continuous variables.
†Notification rate in the year and local authority in which the index case was notified. N=10 476.
aOR, adjusted OR; DOT, directly observed therapy.
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contact tracing outcomes found a grouped yield per contact of
TB in high-income countries of 1.4%,8 a similar study to ours
in Italy found a yield per contact of active disease of 0.71%,17
and a study in Amsterdam found 0.79% of contacts had
prevalent TB and 0.39% incident TB,18 although these com-
parisons do not account for differences in smear-positivity
prevalence. There are no comparable estimates of the yield
per contact of LTBI among child contacts. The overall
prevalence among contacts (1.8%) compares to 0.50% of con-
tacts with prevalent TB and 0.53% with incident TB in a
European study.19
Overall, TB contact tracing in London is performing well
across the suite of indicators when compared with previous
studies in London or elsewhere. Contacts of cases with pulmon-
ary or laryngeal TB are more likely to have TB or LTBI, com-
pared with contacts of cases with non-pulmonary and
Table 5 Associations with evaluated contacts (of index cases with TB at any site) with active TB
Characteristics of the index case Contact diagnosed with active TB
Yes (row %)* No* aOR (95%CI) p Value
Total 263 (1.8%) 14 351 N/a N/a
UK born
Yes 71 (2.3%) 2973 1.31 (0.86 to 1.99) 0.41
No, long-term migrant 159 (1.6%) 9834 1
No, recent migrant 33 (2.1%) 1544 1.23 (0.71 to 2.15)
History of drug use
Yes 18 (2.9%) 612 1.06 (0.56 to 2.01) 0.85
No 245 (1.8%) 13 739 1
History of homelessness
Yes 13 (2.6%) 485 0.77 (0.36 to 1.66) 0.51
No 250 (1.8%) 13 866 1
Former prisoner
Yes 9 (2.8%) 312 1.02 (0.37 to 2.84) 0.96
No 254 (1.8%) 14 039 1
Sex
Male 164 (2.0%) 7884 1.35 (0.95 to 1.91) 0.09
Female 99 (1.5%) 6467 1
Ethnicity
Indian 39 (1.2%) 3130 1 <0.01
Black African 103 (3.0%) 3324 1.95 (1.17 to 3.26)
White 32 (1.7%) 1910 0.81 (0.44 to 1.50)
Other 89 (1.5%) 5987 1.03 (0.63 to 1.67)
Culture
Positive 225 (2.4%) 9316 1 0.12
Negative 71 (0.8%) 4033 0.70 (0.43 to 1.15)
Not done 7 (0.7%) 1002 0.50 (0.23 to 1.09)
Disease type
Non-pulmonary and non-laryngeal 41 (0.6%) 6391 1 <0.01
Pulmonary smear-negative 44 (1.4%) 3107 2.10 (1.20 to 3.69)
Pulmonary smear-positive 166 (4.3%) 3696 6.71 (4.11 to 11.0)
Pulmonary, smear unknown or laryngeal 12 (1.0%) 1157 1.39 (0.73 to 2.64)
BCG
Not vaccinated 51 (1.6%) 3222 0.78 (0.51 to 1.18) 0.28
Vaccinated 177 (2.0%) 8502 1
Unknown 35 (1.3%) 2627 0.73 (0.44 to 1.19)
Clinic case count* (linear, 100 cases/year) x¼ 1:1 s=0.52 0.97 (0.68 to 1.40) 0.89
Age of index case
0–14 years 25 (5.7%) 417 1 <0.01
15 years and over 238 (1.7%) 13 934 0.25 (0.13 to 0.48)
Notification rate*† (linear, 10 cases/100 000 population/year) x¼ 3:7 s=1.9 1.05 (0.95 to 1.17) 0.32
Age of contact
15 years and over 151 (1.5%) 10 133 0.55 (0.40 to 0.75) <0.01
0–14 years 112 (2.6%) 4218 1
Contact screened at clinic
Yes 233 (1.9%) 12 162 1.38 (0.81 to 2.37) 0.24
No 30 (1.4%) 2189 1
*Mean and SD presented for continuous variables.
†Notification rate in the year and local authority in which the index case was notified. N=14 614.
aOR, adjusted OR.
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non-laryngeal TB. However, prevalence of active TB among
contacts of non-pulmonary patients is still very high (0.70%)
relative to background TB prevalence, (0.027% in 200625),
which has implications for the recent change to the National
Institute for Health and Care Excellence (NICE) TB guidelines,
limiting screening to contacts of pulmonary and laryngeal
patients.7
We found that contacts screened at a different clinic to the
index case (accounting for 16% of all contacts) are less likely to
be evaluated than those screened at the same clinic, suggesting
gains can be made by improving cross-clinic contact tracing.
Clinics were increasingly likely to successfully evaluate their
contacts with increasing numbers of DOT and social workers
per index case, indicating the important role played by these
staff in building relationships with patients. Future continuation
of these relationships may be affected by recent policy recom-
mendations, for example, cessation of screening of contacts of
non-pulmonary non-laryngeal patients and screening for LTBI
in all contacts aged under 65 years (previously just under
35 years old).
Further work elucidating how performance against contact
tracing indicators affects transmission and diagnostic delay
Table 6 Associations with evaluated child contacts (of index cases with TB at any site) being diagnosed with LTBI
Characteristic of the index case
Child contact diagnosed with LTBI
Yes (row %)* No* aOR (95% CI) p Value
Total 440 (10%) 3865 N/a N/a
UK born
Yes 113 (16%) 611 1.23 (0.85 to 1.78) 0.44
No, long-term migrant 285 (9%) 2854 1
No, recent migrant 42 (10%) 400 0.87 (0.51 to 1.48)
History of drug use
Yes 29 (18%) 136 1.35 (0.62 to 2.96) 0.45
No 411 (10%) 3729 1
History of homelessness
Yes 17 (14%) 108 0.95 (0.47 to 1.94) 0.90
No 423 (10%) 3757 1
Former prisoner
Yes 8 (10%) 74 0.53 (0.21 to 1.36) 0.19
No 432 (10%) 3791 1
Sex
Male 218 (10%) 1995 0.80 (0.59 to 1.09) 0.16
Female 222 (11%) 1870 1
Ethnicity
Indian 62 (8%) 700 1 0.41
Black African 134 (10%) 1232 1.07 (0.69 to 1.64)
White 72 (18%) 322 1.54 (0.90 to 2.62)
Other 172 (10%) 1611 1.06 (0.71. 1.58)
Culture
Positive 375 (14%) 2283 1 <0.01
Negative 49 (4%) 1260 0.51 (0.34 to 0.76)
Not done 16 (5%) 322 0.60 (0.33 to 1.11)
Disease type
Non-pulmonary and non-laryngeal 67 (3%) 2041 1 <0.01
Pulmonary smear-negative 91 (10%) 823 2.92 (1.96 to 4.35)
Pulmonary smear-positive 252 (27%) 692 8.39 (5.76 to 12.2)
Pulmonary, smear unknown or laryngeal 30 (9%) 309 2.35 (1.35 to 4.10)
BCG
Not vaccinated 87 (10%) 822 0.83 (0.56 to 1.21) 0.54
Vaccinated 280 (11%) 2343 1
Unknown 73 (9%) 700 1.08 (0.72 to 1.60)
Clinic case count* (linear, 100 cases/year) x¼ 1:1 s=0.52 1.22 (0.85 to 1.76) 0.28
Age of index case
0–14 years 30 (18%) 134 1 0.01
15 years and over 410 (10%) 3731 0.40 (0.20 to 0.77)
Notification rate*† (linear, 10 cases/100 000 population/year) x¼ 3:7 s=1.8 1.04 (0.93 to 1.16) 0.45
Contact screened at clinic
Yes 388 (11%) 3306 1.29 (0.83 to 2.01) 0.27
No 52 (8.5%) 559 1
*Mean and SD presented for continuous variables.
†Notification rate in the year and local authority in which the index case was notified. N=4305.
aOR, adjusted OR; LTBI, latent TB infection.
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would be important, as would the impact of recent changes in
procedure to comply with latest national guidance. The recently
changed NICE guidelines recommend limiting screening to pul-
monary and laryngeal cases’ contacts (bringing the UK into line
with many other countries), as well as testing all those aged
under 65 years with TST/IGRA and administering preventive
therapy to this group (rather than just those aged under
35 years), but the implications for cost-effectiveness are unclear.
Cost-effectiveness modelling using data from this study may
help. Completion of cohort review ﬁelds by all clinics has
improved recently; continued high levels of completion of these
ﬁelds would greatly beneﬁt future contact tracing studies.
Further work to understand the full impact of home visits at an
individual level would be useful. This intervention has been
found to aid identiﬁcation and evaluation of contacts in the
USA26 and Portugal,27 and to improve preventive therapy out-
comes in the USA and Canada,28 but our analysis was unable to
show a relationship between home visits and improved contact
identiﬁcation and evaluation. Finally, qualitative research into
improving engagement with men and those with prison history
could potentially improve the proportion of contacts success-
fully evaluated, as these groups are less likely (compared with
women and those without a prison history, respectively) to have
contacts identiﬁed and evaluated (for men) but do not necessar-
ily have lower yields per contact, suggesting room for
improvement.
Acknowledgements The authors thank Jacqui Carless, Lamya Kanfoudi and
others at Public Health England (PHE) ﬁeld Epidemiology London for maintaining the
LTBR; all nurses and other healthcare workers involved with collecting the data and
presenting it at cohort review; Johan van Wijgerden for providing data on London
clinic stafﬁng levels; Ayoub Saei for statistical advice; the TB modelling group at
LSHTM for advice on presentation and approach; and Lindsay Serene for comments
on the manuscript.
Contributors SMC conceived and designed the work with input from TS, EV,
RGW, HLT, HM and CA. CA and HM are responsible for the acquisition and
maintenance of the data. SMC undertook the analysis with advice from all other
authors. All authors contributed to the interpretation of the data. SMC wrote the
ﬁrst draft of the paper and all authors contributed to subsequent drafts. All authors
approve the work for publication and agree to be accountable for the work.
Funding SMC is funded by a joint PHE-LSHTM studentship in Infectious Disease
Modelling. RGW is funded by the UK Medical Research Council (MRC) and the UK
Department for International Development (DFID) (under the MRC/DFID Concordat
agreement that is also part of the EDCTP2 programme supported by the European
Union (MR/J005088/1)), the Bill and Melinda Gates Foundation (TB Modelling and
Analysis Consortium: OPP1084276, and SA Modelling for Policy: #OPP1110334)
and UNITAID (4214-LSHTM-Sept15; PO #8477-0-600). CA, EV, HM and HLT are
employed by PHE, a government agency, and received no other source of funding.
TS is funded by the Bill and Melinda Gates Foundation (SA Modelling for Policy:
#OPP1110334).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with the
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits
others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: http://creativecommons.org/licenses/
by/4.0/
REFERENCES
1 World Health Organization. Global Tuberculosis Report 2016. Geneva: World Health
Organization, 2016.
2 Davidson JA, Lalor MK, Mohiyuddin T, et al. Tuberculosis in the UK: 2016 report.
London: Public Health England, 2016.
3 Collaborative Tuberculosis Strategy for England: 2015 to 2020. London: Public
Health England, NHS England, 2015.
4 Tuberculosis in London: Annual review (2014 data). London: Public Health England,
2015.
5 Hamblion EL, Le Menach A, Anderson LF, et al. Recent TB transmission, clustering
and predictors of large clusters in London, 2010–2012: results from ﬁrst 3 years of
universal MIRU-VNTR strain typing. Thorax 2016;71:749–56.
6 Erkens CG, Kamphorst M, Abubakar I, et al. Tuberculosis contact investigation in
low prevalence countries: a European consensus. Eur Respir J 2010;36:925–49.
7 NICE Tuberculosis Guidance. http://www.nice.org.uk/guidance/CG117
8 Fox GJ, Barry SE, Britton WJ, et al. Contact investigation for tuberculosis: a
systematic review and meta-analysis. Eur Respir J 2013;41:140–56.
9 Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung
Dis 1992;73:73–6.
10 Munsiff SS, Ahuja SD, King L, et al. Ensuring accountability: the contribution of the
cohort review method to tuberculosis control in New York City. Int J Tuberc Lung
Dis 2006;10:1133–9.
11 Anderson C, White J, Abubakar I, et al. Raising standards in UK TB control:
introducing cohort review. Thorax 2014;69:187–9.
12 Mandal P, Craxton R, Chalmers JD, et al. Contact tracing in pulmonary and
non-pulmonary tuberculosis. QJM 2012;105:741–7.
13 Rubilar M, Brochwicz-Lewinski MJ, Anderson M, et al. The outcome of contact
procedures for tuberculosis in Edinburgh, Scotland 1982–1991. Respir Med
1995;89:113–20.
14 Saunders MJ, Koh GC, Small AD, et al. Predictors of contact tracing completion and
outcomes in tuberculosis: a 21-year retrospective cohort study. Int J Tuberc Lung Dis
2014;18:640–6.
15 Mulder C, Klinkenberg E, Manissero D. Effectiveness of tuberculosis contact tracing
among migrants and the foreign-born population. Euro Surveill 2009;14:19153.
16 MacIntyre CR, Plant AJ. Impact of policy and practice on the effectiveness of contact
screening for tuberculosis. Prev Med 1998;27:830–7.
17 Borraccino A, Migliore E, Piccioni P, et al. Yield of tuberculosis contact investigation
in a low-incidence country. J Infect 2014;68:448–54.
18 Sloot R, Schim van der Loeff MF, Kouw PM, et al. Risk of tuberculosis after recent
exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit
Care Med 2014;190:1044–52.
19 Zellweger JP, Sotgiu G, Block M, et al. Risk assessment of tuberculosis in contacts
by IFN-gamma release assays. A tuberculosis network European trials group study.
Am J Respir Crit Care Med 2015;191:1176–84.
20 National Tuberculosis Controllers Association; Centers for Disease Control and
Prevention (CDC). Guidelines for the investigation of contacts of persons with
infectious tuberculosis. Recommendations from The National Tuberculosis Controllers
Association and CDC. MMWR Recomm Rep 2005;54(RR15):1–47.
21 World Health Organization. Recommendations for investigating contacts of persons
with infectious tuberculosis in low- and middle-income countries. Geneva: World
Health Organization, 2012.
22 Sandgren A, Magalhaes I. Management of contacts of MDR TB and XDR TB
patients. Stockholm: European Centre for Disease Prevention and Control, 2012.
23 Williams RL. A note on robust variance estimation for cluster-correlated data.
Biometrics 2000;56:645–6.
24 Young KH, Ehman M, Reves R, et al. Tuberculosis Contact Investigations—United
States, 2003–2012. MMWR Morb Mortal Wkly Rep 2016;64:1369–74.
25 Story A, Murad S, Roberts W, et al. Tuberculosis in London: the importance of
homelessness, problem drug use and prison. Thorax 2007;62:667–71.
26 Marks SM, Taylor Z, Qualls NL, et al. Outcomes of contact investigations of
infectious tuberculosis patients. Am J Respir Crit Care Med 2000;162:2033–8.
27 Duarte R., Neto M, Carvalho A, et al. Improving tuberculosis contact tracing: the role
of evaluations in the home and workplace. Int J Tuberc Lung Dis 2012;16:55–9.
28 Fiske CT, Yan FX, Hirsch-Moverman Y, et al. Risk factors for treatment default in close
contacts with latent tuberculous infection. Int J Tuberc Lung Dis 2014;18:421–7.
10 Cavany SM, et al. Thorax 2017;0:1–10. doi:10.1136/thoraxjnl-2016-209677
Tuberculosis
